September 11, 2008 - The American College of Cardiology (ACC) has certified LUMEDX an ACC-NCDR CARE Registry software vendor, making LUMEDX the first vendor certified for carotid stent procedures.

LUMEDX's Export to CARE Registry solution is the latest in a suite of software applications developed to address the growing need for impeccable, accessible vascular data, streamlined clinical workflows and superior data management.

TeraRecon Inc. released new innovations in its flagship Aquarius iNtuition client-server to empower nuclear cardiologists to improve efficiency within their cardiac imaging portfolio.

September, 10, 2008 - Members of the Venous Disease Coalition (VDC) and the Office of the Surgeon General will unite to urge immediate action in the fight against deadly blood clots known as deep vein thrombosis (DVT) on Sept. 15. at the VDC Annual Meeting at The Grand Hyatt Hotel, Washington, D.C.

September 10, 2008 - CardioVascular BioTherapeutics Inc. announced yesterday that the first U.S. site is open for patient enrollment in the company’s Phase II clinical trial for the treatment of severe coronary heart disease.
CVBT anticipates announcing the opening of additional sites for enrollment in the coming weeks.

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System.

Boston Scientific said the PROMUS Stent is highly deliverable, made from cobalt chromium, which allows for thinner struts without sacrificing strength or visibility.

September 9, 2008 - Lantheus Medical Imaging Inc. issued a statement assuring regulatory authorities, key customers and partners that they will continue to receive supply of molybdenum-99 (Mo-99), the parent isotope of Technetium-99m (Tc-99m) in their TechneLite generators, during the current global isotope shortage and will continue to fulfill preexisting standing orders and try to meet additional demands during this critical time.

September 9, 2008 - Ventricular assist device manufacturer MicroMed Cardiovascular Inc. today said it completed all necessary steps and is now a private company.

The final step in the process was a reverse split of its common stock and a repurchase of the fractional shares from the MicroMed shareholders holding smaller positions. At the time of the reverse split, E-Wilson LLC had accumulated 97.5 percent of the outstanding MicroMed shares. MicroMed received confirmation of the reverse split on Aug. 25, 2008, making E-Wilson the single shareholder of MicroMed.

September 9, 2008 - Celera Corp. and its collaborators at Brigham and Women’s Hospital today said a paper published in Atherosclerosis Journal reports a variant of the LPA gene is associated with a two-fold higher risk of major cardiovascular events (myocardial infarction, ischemic stroke and cardiovascular death).

September 9, 2008 - CoreValve said today five clinical evaluation sites (two in New Zealand and three in Australia) have now completed their first series of proctored cases using the company’s proprietary ReValving System for percutaneous aortic valve replacement (PAVR), which features a porcine pericardium valve mounted in a self-expanding frame.

Pathway Medical Technologies Inc. offers the Jetstream, a peripheral atherectomy catheter designed for use in the treatment of peripheral artery disease (PAD) in the lower limbs. The device is capable of treating an entire spectrum of disease found in the PAD patient, including hard and soft plaque, calcium, thrombus and fibrotic lesions with consistent clinical results, the company said.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now